ROPINIROLE TEVA 0.25 mg, film-coated tablet 21 tablets
Active ingredients: Ropinirole hydrochloride, Ropinirol
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet21 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ROPINIROLE TEVA 0,25 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) polyamide aluminium PVC-Aluminium de 21 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>Maladie de Parkinson dans les conditions suivantes :<br><br>- En monothérapie et en première intention<br>- En association à la lévodopa ; JOURNAL OFFICIEL ; 27/01/12
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Apr 2010
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64255608CIP73930248CIP133400939302485Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPINIROLEcomprimé | 0,285 mg · un comprimé | SA |
| ROPINIROLE BASEcomprimé | 0,25 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.